Zaroxolyn and Arthritis bacterial - a phase IV clinical study of FDA data

Summary:

Arthritis bacterial is reported only by a few people who take Zaroxolyn.

The phase IV clinical study analyzes which people take Zaroxolyn and have Arthritis bacterial. It is created by eHealthMe based on reports of 5,108 people who have side effects while taking Zaroxolyn from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

5,108 people reported to have side effects when taking Zaroxolyn.
Among them, 3 people (0.06%) have Arthritis bacterial.

What is Zaroxolyn?

Zaroxolyn has active ingredients of metolazone. It is often used in high blood pressure. eHealthMe is studying from 5,126 Zaroxolyn users for its effectiveness, alternative drugs and more.

What is Arthritis bacterial?

Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection) is found to be associated with 927 drugs and 500 conditions by eHealthMe.

Number of Zaroxolyn and Arthritis bacterial reports submitted per year:

Could Zaroxolyn cause Arthritis bacterial?

Gender of people who have Arthritis bacterial when taking Zaroxolyn *:

female: 66.67 %
male: 33.33 %

Age of people who have Arthritis bacterial when taking Zaroxolyn *:

Common drugs people take besides Zaroxolyn *:

Common side effects people have besides Arthritis bacterial *:

Pain: 2 people, 66.67%
Pain In Extremity: 2 people, 66.67%
Gout (uric acid crystals building up in the body): 2 people, 66.67%
Infection: 2 people, 66.67%
Wound Infection Staphylococcal: 1 person, 33.33%
Family Stress: 1 person, 33.33%
Diarrhea: 1 person, 33.33%
Dilatation Ventricular: 1 person, 33.33%
Disease Recurrence: 1 person, 33.33%
Dizziness: 1 person, 33.33%

Common conditions people have *:

Oedema (fluid collection in tissue): 2 people, 66.67%
Limb Injury: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zaroxolyn and have Arthritis bacterial?

Check whether Arthritis bacterial is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Arthritis bacterial and when was it recovered:

Arthritis bacterial in Zaroxolyn

Expand to all the drugs that have ingredients of metolazone:

Arthritis bacterial and drugs with ingredients of metolazone

Alternative drugs to, pros and cons of Zaroxolyn:

Zaroxolyn (5,126 reports)

Common Zaroxolyn side effects:

Breathing difficulty: 597 reports
Weakness: 543 reports
Pain: 498 reports
Hypotension (abnormally low blood pressure): 455 reports

Browse all side effects of Zaroxolyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Arthritis bacterial treatments and more:

Arthritis bacterial (5,413 reports)

COVID vaccines that are related to Arthritis bacterial:

Common drugs associated with Arthritis bacterial:

All the drugs that are associated with Arthritis bacterial:

Arthritis bacterial (928 drugs)

Common conditions associated with Arthritis bacterial:

Rheumatoid arthritis: 1,204 reports
High blood pressure: 190 reports
Pain: 186 reports
Osteoporosis: 132 reports

All the conditions that are associated with Arthritis bacterial:

Arthritis bacterial (500 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metolazone (the active ingredients of Zaroxolyn) and Zaroxolyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.